Related Experiment Video
Updated: Jul 17, 2026

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
[Smoking in adolescents: prevalence, clinical manifestations, preventive measures]
F Beck1, S Legleye, P Peretti-Watel
1Observatoire Français des Drogues et des Toxicomanies, France. frbec@ofdt.fr
Introduction:
Since the late 1990s, several French surveys have studied perceptions about and the use of tobacco and other drugs among adolescents. This enables to track trends in tobacco use at this crucial age. This article presents the main epidemiological data gathered since 2000 and also reviews older surveys in order to place recent trends in a broader perspective.
State Of The Art:
Thus, tobacco use has been decreasing in adolescents for several years but remains at a higher level than in the adult French population or than in many other European countries. This pattern is linked with a clearer view of the dangers of tobacco in terms of addiction and related harms, compared with alcohol and cannabis.
Perspectives:
The results vary according to social background and level of educational attainment and echo similar trends in adult populations.
Conclusions:
General population surveys can provide useful data for the monitoring and the understanding of trends in tobacco use. They can also provide useful information regarding prevention for policy makers and other health professionals.
Related Concept Videos
Stress Prevention and Stress Management Techniques IV
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Asthma III: Clinical Manifestations
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease I: Introduction

